Biobanking Global Congress 2013 Europe

SL51

Background Info

Biobanking Global Congress 2013 Europe

Paradigm Global Events is proud to present The Biobanking Global Congress 2013 Europe.

The biobanking industry is growing at an exponential rate, as researchers realise the growing importance of using samples for R&D. This growth leads to several issues, commercial, ethical, and scientific.

There are three main strands to this conference: firstly the growth of biobank networks: what does this mean to researchers, how can standards be harmonized, and how can organisations collaborate successfully?

Secondly, the conference will examine the ethical and legal issues of biobanking – including a look at ownership and informed consent; how can you get proper consent for the samples and how can you prove that all steps have been taken to ensure ownership protocols?

Lastly, data management is a huge issue for biobanks, as they grow in size, how are the samples stored, how is the data pertaining to the samples managed, and how can biobanks make effective use of data for their own purposes?

Not only will these three issues be discussed, but the event will also look at drug discovery for biobanks, quality assurance, and include a case study.

Don’t miss this opportunity – Reason to register today and – Why Attend?

• The most up-to-date information on Sample Storage and Tracking Issues
• Review the development and implementation of a tissue repository
• Hear the latest on the Stem Cell Banking
• Discuss the changing approaches to target-finding, drug development and patient treatment
• Gain a clearer insight on Green Banking
• Understanding the regulatory social and ethical frameworks
• Examine the quality concerns for existing biospecimen collections
• Recognise the importance of biobanking in rare disorders
• Analyse major challenges for biorepository management and implementation
• Get the latest update on the application

Worldwide Biobanking market is to increase by 30% to reach an estimated $183 Billion by 2015.

A “Must attend??? Biobanking Conference for 2013 for:
VPs, Directors, Heads, Managers of:
• Biobanks
• Tissue bank
• Biorepository / Biosample
• Translational Medicine
• Personalised Medicine
• Biomarkers Development
• Compound Management
• Digital Pathology
• Laboratory Automation
• Oncology Clinical Research
• Liquid Handling
• DNA Methylation
• Laboratory and Inventory
• Molecular Diagnostics
• Clinical Genetics, Pathology
• Genomics
• Scientific and Quality
• Privacy / Protections / Security
• R & D
• Quality Control
• Strategic Outsourcing
• Clinical Research
• Bioanlytical Chemistry
• Pharmacogenomics
• Proteomics
• Business Development
• Strategic Alliances
• Histopathology
• Non-clinical Biosample
• Health Science Policy
• Toxicology, Clinical Chemistry
• Clinical trials and Non-clinical R & D
• Procurement and Strategic Sourcing
• Informatics

Others:
Consultants, Academics, Regulatory bodies, Researchers, Biorepository Vendors, Government Officials[/tab]

Key Speakers


Day 1


Day 1 – 11th September 2013

09:00-09:30 – Registration & Coffee – Exhibitors Hall

09:30-09:40 – Chair’s welcome –
Dr. Kirstin Goldring, UCL School of Life and Medical Sciences

09:40-10:20 – Biobanking for Stratified Medicine: Overcoming the challenge of clinical data
• Embedding biobanking in the NHS
• Capturing and stratifying clinical data exchange in the NHS
• Aligning clinical data with tissue resources
Dr. Brian Thomson, Director of R&D, Nottingham Integrated Clinical Research Centre, Nottingham University Hospital NHS Trust

10:20-11:00 – The Role of the Virtual Biobank in Supporting Commercial Research
• What is a virtual biobank and what are the pro’s and cons of working with them?
• How a virtual biobank can adapt to the changing tissue requirements driven by commercial research needs.
• What are the advantages of virtual sample collection on an “on demand??? basis?
Morag McFarlane, PhD, Chief Scientific Officer, Tissue Solutions Ltd

11:00-11:40 – Networking Morning – Refreshments – Exhibitors Hall

11:40-12:20 Solutions and advantages for large scale Genetic Profiling of Biobanks
Scott Brouilette, Marketing Sequencing Specialist – UK & Ireland, Illumina

12:20-13:00 Brain Banking to meet current research needs
• Brain Banking in the UK: tissue collection, diagnosis, quality and access
• Increasing the scientific value of donated tissue through cohort recruitment and longitudinal assessment
• The challenges of non-standard sample storage and tracking
• The future: network coordination and multi-sample biobanks
Dr. Claire Troakes, Brain Bank Coordinator, London Neurodegenerative Disease Brain Bank Institute of Psychiatry, King’s College London

13:00-14:00 – Networking Lunch – Exhibitors Hall

14:00-14:40 – The Challenges of Supporting varied sample collections and resources in Academia: The UCL Experience
• Supporting complex biobanking requirements
• Ensuring value from varied collections
• Experiences and challenges
• The NIHR BioResource model
Dr Kirstin Goldring, UCL Biobank and BioResource Coordinator, UCL School of Life and Medical Sciences

14:40-15:20 – Ethical considerations of Biobanking
• Who gives informed consent?
• Who decides how the sample is used?
• Who effectively owns the sample?
• Other issues e.g. Privacy, protection
Dr. Alison Parry-Jones, Manager, Wales Cancer Bank Cardiff University

15:20-16:00 – Networking Afternoon – Refreshments – Exhibitors Hall

16:00-16:40 – Developing an Effective Consent Form
• Introduction to EU Personal Data Protection principles and their application to Human Biological Samples
• Coding, withdrawal & Re-Using of personal data and biological samples
• What should be included in the Informed Consent Form?
• Last updates regarding the New EU Data Protection regulation draft
Anne BAHR, Ph.D, CIPP/E, R&D Data Privacy Officer, R&D Compliance department, Sanofi – Aventis

16:40-17:20 – PANEL: ETHICS AND BIOBANKING – A panel discusses the ethical considerations relating to biobanking
Dr. Alison Parry-Jones, Manager, Wales Cancer Bank Cardiff University
Anne BAHR, Ph.D, CIPP/E, R&D Data Privacy Officer, R&D Compliance department, Sanofi – Aventis
Morag McFarlane, PhD, Chief Scientific Officer, Tissue Solutions Ltd

17:20-17:30 Chair comments – End of day one

17:30 – Networking Drinks Reception at the Exhibitors hall.
Take your discussions further and build new relationships in a relax and informal settings.

 

Day 2


Day 2 – 12th September 2013

09:00-09:30 – Registration & Coffee – Exhibitors Hall

09:30-09:40 – Chairman’s opening comments – Dr. Morag McFarlane, Tissue Solutions Ltd

09:40-10:20 – Research Biobanking as a Facilitator for Biomarker Discovery and Assay Validation
• A solid concept ensures compliance and best practice
• Improving collaboration between clinical academia, biotechs and pharma industry by identifying mutual win-wins
• Validating initial findings in translational research – bed to benchside and back
• Assay validation as key task often underestimated
• Collaboration case study in oncology, our AACR 2013 poster 3486
Dr. Arndt Schmitz is Head of Research Biobank at Bayer pharma’s Global Drug Discovery unit

10:20-11:00 – Drug Development and biobanking
• What does the increased capability of biobanking mean for clinical research?
• Open-sourcing and using samples for drug development
• Obstacles for drug development
Amelia Wall Warner, PharmD, Head Clinical Pharmacogenomics and Clinical Specimen, Management, Merck & Co Inc.

11:00-11:40 – Networking – Morning Refreshments – Exhibitors Area

11:40-12:20 – PANEL: QUALITY MANAGEMENT AND ASSURANCE
• The panel discusses issues and strategies for quality management in biobanks
Nicola J Reeves, Manager, Informatics, Data and Sample Management Human Sample BioRepository (HSBR), GlaxoSmithKline
Amelia Wall Warner, PharmD, Head Clinical Pharmacogenomics and Clinical Specimen, Management, Merck & Co Inc.

12:20-13:00 – CASE STUDY: Transitioning DNA biobank and distribution service from in-house to an external provider: Challenges and considerations
Nicola J Reeves, Manager, Informatics, Data and Sample Management Human Sample BioRepository (HSBR), GlaxoSmithKline

13:00-14:00 – Networking Lunch – Exhibitors Hall

14:00-14:40 – Biobanking and comprehensive molecular diagnostics as the basis for effective personalized medicine- Bringing patients and relevant early clinical trials together.
• The experience of the Network Genomic Medicine, Lung Cancer Group Cologne
• Overcoming the challenges in sample collection in a routine diagnostic testing.
• A Biobank is only as good as it’s sample annotation- tools for linking different data sources for ad hoc searches.
• Successfully linking clinical, pathological, molecular and follow-up as a basis for patient stratification for targeted early clinical trials.
Lukas C Heukamp, Pathologist and Director, Biobank of the Centre for Integrated Oncologe Cologne/ Bonn Biobank

14:40-15:20 – A Broad Data Strategy for Biobanking
• While much attention has been devoted to big data handling, the key to stratifying patients, diagnoses and treatments is in complete and confident access to diverse data types from bench to bedside and back. Join us in presenting • Broad Data approaches that span biospecimen, clinical, laboratory and research domains in order to drive clinical and translational research.
Hank Wu, Director, Translational Informatics, Remedy Informatics, USA

15:20-16:00 – Networking – Afternoon Refreshments – Exhibitors Area

16:00-16:40 – Data infrastructure and big data
• Explosive growth in data means a need for effective data infrastructure system
• Managing data growth successfully
• Drilling down into data for validation
(Speaker to be announced shortly)

16:40-17:00 – Chairman’s closing comments and end of conference

Sponsors


Associate Sponsors


At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. Our products and services are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
www.illumina.com

Exhibitors


EXCILONE, is a French company base near Paris.

We design, develop and market innovative solutions for biobanking.
– RCL2®, Formalin free tissue fixative, to combine Histology and Molecular techniques
– SNAPFROST®, A liquid Nitrogen free snapfreezing system, to obtain the best morphology on frozen tissue section
– CRESALYS®, Biobank Management System to increase the value of your sample collection.
CRESALYS®, allows you to manage : Patient demographics, Epidemiology and History, Family link, Patient follow up, Clinical Data, Pathology Report, Specimen Reception and storage, Specimen Retrieval, Quality Management,…

Partners

Media Partners

PharmaVOICE magazine provides commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE’s more than 25,000 BPA-qualified subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers. For further information please visit: www.pharmavoice.com

Biocompare is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit www.biocompare.com to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news. For further information please visit: www.biocompare.com

European Life Science is the premier journal devoted to presenting outstanding research and researchers within the life science fields. For further information please visit: www.life-science.se

SelectScience.net is the leading online product and application publication for laboratory scientists featuring the latest news, application articles, videos, product directory and product reviews. Membership is fast, free and provides access to all of the SelectScience services. SelectScience.tv is a unique video news channel for laboratory application and product information. For further information please visit: www.selectscience.net

InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile and Pharmafocus. For further information please visit: www.In-Pharm.com

PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email: corporate@pharmiweb.com

BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com

Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision- makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries’ top issues and the solutions top-tier vendors can provide. For further information please visit: www.futurepharmaus.com
[tab title=”Venue”]Holiday Inn Bloomsbury
Coram Street, London
WC1N 1HT, United Kingdom

Reservations: 0871 942 9094
Hotel Direct: 0871 942 9222
Web: www.hilondonbloomsburyhotel.co.uk

Paradigm Global Events (UK Office)
86-90 Paul Street
London, EC2A 4NE
Tel: +44 (0)20 7193 3485
EMAIL: info@paradigmglobalevents.com

Paradigm Global Events (China Office)
19-9, Unit Two, Hejingjurong Plaza
No.1 Minsheng Road. Yuzhong. China.
Tel: +86 150 8665 2824
EMAIL: info@paradigmglobalevents.com